Moreover, POU6F2-AS1 specifically tethers YBX1 to the FASN promoter to activate its transcription, leading to the enhanced expression of this key enzyme in the de novo synthesis of FAs, thereby facilitating the progression of CRC. This evidence concerns the gene FASN and colorectal carcinoma.